DrugPredict Wins $2.8M NIH Grant to Repurpose Approved Therapies to Treat Alzheimer’s

DrugPredict Wins $2.8M NIH Grant to Repurpose Approved Therapies to Treat Alzheimer’s
A group of U.S. researchers hoping to identify already approved medications to repurpose as Alzheimer’s disease treatments has won a $2.8 million, five-year grant from the National Institute on Aging, a division of the National Institutes of Health (NIH). The study will be led by scientists at Ohio's Case Western Reserve University School of Medicine. The group recently launched a computer program called DrugPredict that links medication characteristics with data on how a treatment might affect disease-associated factors. DrugPredict has already identified new uses for old drugs. The grant money will help researchers will develop computer algorith
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *